CanSense’s test is a blood-based assay that uses laser spectroscopy and artificial intelligence to identify early-stage colorectal cancer and precancerous polyps.
Keep Reading
Add A Comment
Trending
- CRISPR patent decisions could trigger waves globally (Lab Pulse)
- Geneoscopy Receives New York State Department of Health Permit, Expanding Ability to Provide Laboratory Services Nationwide (Business Wire)
- Opinion How ‘obesity first’ health care is transforming medicine (The Washington Post)
- Remote-controlled robot is changing the game for endoscopes (Advanced Science News)
- 5 notes on the future of GI growth (Becker’s GI & Endoscopy)
- Blue Cross Blue Shield Of Massachusetts Encourages Members To Discuss Colorectal Cancer Screening With Their Doctor (Blue Cross Blue Shield of Massachusetts)
- Biosimilar costs escalate for GI practices (AGA)
- Fourth Ustekinumab Biosimilar, Otulfi, Approved in US (AJMC)
